A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein

Oncogene

Volumn 18, Issue 50, 1999, Pages 7026-7033

  Veldhoen, Nik ^a   Metcalfe, Su ^b   Milner, Jo ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alternative splicing; mdm2; p53; Regulatory exon

Indexed keywords

MESSENGER RNA; PROTEIN MDM2; PROTEIN P53;

ARTICLE; BINDING SITE; CONTROLLED STUDY; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; NORMAL HUMAN; ONCOGENE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; STOP CODON; TESTIS; TISSUE SPECIFICITY; TRANSLATION INITIATION;

EID: 0033604463     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203182     Document Type: Article

References (52)

1. Almon E, Goldfinger N, Kapon A, Schwartz D, Levine AJ and Rotter V. (1993). Dev. Biol., 156, 107-116.
2. Barak Y, Gottlieb E, Juven-Gershon T and Oren M. (1994). Genes Dev., 8, 1739-1749.
3. Böttger A, Böttger V, Garcia-Echeverria C, Chène P, Hochkeppel H-K, Sampson W, Ang K, Howard SF, Picksley SM and Lane DP. (1997). J. Mol. Biol., 269, 744-756.
4. Bruening W and Pelletier J. (1996). J. Biol. Chem., 271, 8646-8654.
5. Cahilly-Snyder L, Yang-Feng T, Francke U and George DL. (1987). Somat. Cell Mol. Genet., 13, 235-244.
6. Chen J, Maréchal V and Levine AJ. (1993). Mol. Cell. Biol., 13, 4107-4114.
7. Cook A and Milner J. (1990). Br. J. Cancer, 61, 548-552.
8. Elenbaas B, Dobbelstein M, Roth J, Shenk T and Levine AJ. (1996). Mol. Med., 2, 439-451.
9. Fakharzadeh SS, Trusko SP and George DL. (1991). EMBO J., 10, 1565-1569.
10. Freedman DA, Epstein CB, Roth JC and Levine AJ. (1997). Mol. Med., 3, 248-259.
11. Gamble J and Milner J. (1988). Virology, 162, 452-458.
12. Gellersen B, Kempf R and Telgmann R. (1997). Mol. Endocrin., 11, 97-113.
13. Gudas JM, Nguyen H, Klein RC, Katayose D, Seth P and Cowan KH. (1995). Clin. Cancer Res., 1, 71-80.
14. Haines DS. (1997). Leuk. Lymph., 26, 227-238.
15. Haines DS, Landers JE, Engle LJ and George DL. (1994). Mol. Cell. Biol., 41, 1171-1178.
16. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
17. Honda R, Tanaka H and Yasuda H. (1997). FEBS Lett., 420, 25-27.
18. Honda R and Yasuda H. (1999). EMBO J., 18, 22-27.
19. Jones SN, Ansari-Lari MA, Hancock AR, Jones WJ, Gibbs RA, Donehower LA and Bradley A. (1996). Gene, 175, 209-213.
20. Juven-Gershon T, Shifman O, Unger T, Elkeles A, Haupt Y and Oren M. (1998). Mol. Cell. Biol., 18, 3974-3982.
21. Kaufman RJ, Murtha P and Davies MV. (1987). EMBO J., 6, 187-193.
22. Kraus A, Neff F, Behn M, Schuermann M, Muenkel K and Schlegel J. (1999). Int. J. Cancer, 80, 930-934.
23. Kubbatat MHG and Vousden KH. (1998). Mol. Med., 4, 250-256.
24. Kussie PH, Gorina S, Maréchal V, Elenbaas B, Moreau J, Levine AJ and Pavletich NP. (1996). Science, 274, 948-953.
25. Leng P, Brown DR, Shivakumar CV, Deb S and Deb SP. (1995). Oncogene, 10, 1275-1282.
26. Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP and Finlay CA. (1997). Genes Dev., 11, 714-725.
27. Luukkonen BG, Tan W and Schwartz S. (1995). J. Virol., 69, 4086-4094.
28. Maréchal V, Elenbaas B, Piette J, Nicolas JC and Levine AJ. (1994). Mol. Cell. Biol., 14, 7414-7420.
29. Maréchal V, Elenbaas B, Taneyhill L, Piette J, Mechali M, Nicolas J-C, Levine AJ and Moreau J. (1997). Oncogene, 14, 1427-1433.
30. Martin K, Trouche D, Hagemeier C, Sørenson TS, La Thangue NB and Kouzarides T. (1995). Nature, 375, 691-694.
31. Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y and Abe H. (1998). Cancer Res., 58, 609-613.
32. Maxwell SA. (1994). Anticancer Res., 14, 2541-2548.
33. McCaughan KK, Brown CM, Dalphin ME, Berry MJ and Tate WP. (1995). Proc. Natl. Acad. Sci. USA, 92, 5431-5435.
34. Momand J, Jung D, Wilczynski S and Niland J. (1998). Nucl. Acids Res., 26, 3453-3459.
35. Momand J and Zambetti GP. (1997). J. Cell. Biochem., 64, 343-352.
36. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
37. Montes de Oca Luna R, Tabor AD, Eberspaecher H, Hulboy DL, Worth LL, Colman MS, Finlay CA and Lozano G. (1996). Genomics, 33, 352-357.
38. Montes de Oca Luna R, Wagner DS and Lozano G. (1995). Nature, 378, 203-206.
39. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B. (1992). Nature, 358, 80-83.
40. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
41. Olson DC, Marechal V, Momand J, Chen J, Romocki C and Levine AJ. (1993). Oncogene, 8, 2353-2360.
42. Padgett RA, Grabowski PJ, Konarska MM, Seiler S and Sharp PA. (1986). Annu. Rev. Biochem., 55, 1119-1150.
43. Piette J, Neel H and Maréchal V. (1997). Oncogene, 15, 1001-1010.
44. Roth R, Dobbelstein M, Freedman DA, Shenk T and Levine AJ. (1998). EMBO J., 17, 554-564.
45. Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Simons A, Wolkowicz R, Lavigne M, Beserman P, Kapon A and Goldfinger N. (1994). Semin. Cancer Biol., 5, 229-236.
46. Rotter V, Schwartz D, Almon E, Goldfinger N, Kapon A, Meshorer A, Donehower LA and Levine LA. (1993). Proc. Natl. Acad. Sci. USA, 90, 9075-9079.
47. Saucedo LJ, Myers CD and Perry ME. (1999). J. Biol. Chem., 274, 8161-8168.
48. Sigalas I, Calvert AH, Anderson JJ, Neal DE and Lunec J. (1996). Nat. Med., 2, 912-917.
49. Shick L, Carman JH, Choi JK, Somasundaram K, Burrell M, Hill DE, Zeng Y-X, Wang Y, Wiman KG, Salhany K, Kadesch TR, Monroe JG, Donehower LA and El-Deiry WS. (1997). Cell Growth Diff., 8, 121-131.
50. Sun P, Dong P, Dai K, Hannon GJ and Beach D. (1998). Science, 282, 2270-2272.
51. Veldhoen N and Milner J. (1998). Oncogene, 16, 1077-1084.
52. Xiao Z-X, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM. (1995). Nature, 375, 694-698.